Proliferative and protective effects of SurR9-C84A on differentiated neural cells

Journal of Neuroimmunology

Volumn 227, Issue 1-2, 2010, Pages 120-132

  Baratchi, Sara ^a   Kanwar, Rupinder K ^a   Cheung, Chun Hei Antonio ^b   Kanwar, Jagat R ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Neurodegenerative disease; Neuroproliferation; Neuroprotection; SurR9 C84A

Indexed keywords

BETA ACTIN; CASPASE 3; CYCLIN D1; RETINOIC ACID; SURVIVIN; SURVIVIN SURR9 C84A; UNCLASSIFIED DRUG; ALANINE; ARGININE; BIRC5 PROTEIN, MOUSE; CYSTEINE; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BINDING; REPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CELL ACTIVATION; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INTERNALIZATION; MICROTUBULE; MITOSIS; MITOSIS SPINDLE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AMINO ACID SUBSTITUTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY; TOXICITY; TUMOR CELL LINE;

ALANINE; AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; ARGININE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICROTUBULES; MUTATION; NEURONS; PROTEIN BINDING; REPRESSOR PROTEINS; TRETINOIN;

EID: 77956648003     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.024     Document Type: Article

References (54)

1. Altieri D.C. T cell expansion: the survivin interface between cell proliferation and cell death. Immunity 2005, 22:534-535.
2. Altieri D.C. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 2006, 18:609-615.
3. Altieri D.C. Opinion - survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 2008, 8:61-70.
4. Baratchi S., Kanwar R.K., Khoshmanesh K., Vasu P., Ashok C., Hittu M., Parratt A., Krishnakumar S., Sun X.Y., Sahoo S.K., Kanwar J.R. Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases. Current Nanoscience 2009, 5:15-25.
5. Blancas S., Moran J. Role of Inhibitory Apoptosis Proteins in the Survival of Cerebellar Granule Neurons in Culture 2007, 258-258. Blackwell Publishing.
6. Bolton M.A., Lan W.J., Powers S.E., McCleland M.L., Kuang J., Stukenberg P.T. Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and in a complex inase activity is phosphorylation. Mol. Biol. Cell 2002, 13:3064-3077.
7. Chang P.A., Chen R., Wu Y.J. Reduction of neuropathy target esterase does not affect neuronal differentiation, but moderate expression induces neuronal differentiation in human neuroblastoma (SK-N-SH) cell line. Molecular Brain Research 2005, 141:30-38.
8. Cheung C.H.A., Kanwar J., Krissansen G.W. A cell-permeable dominant-negative survivin protein as a tool to understand how survivin maintains tumour cell survival. Ejc Supplements 2006, 4:488.
9. Deligezer U., Erten N., Akisik E.E., Dalay N. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma. Exp. Mol. Pathol. 2006, 80:72-76.
10. Eyers P. Survivin(g) phosphorylation? Survivin phosphorylation, mitosis and apoptosis. Cell Cycle 2009, 8:183-184.
11. Fortugno P., Wall N.R., Giodini A., O'Connor D.S., Plescia J., Padgett K.M., Tognin S., Marchisio P.C., Altieri D.C. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. 2002, 115:575-585.
12. Ghosh J.C., Dohi T., Kang B.H., Altieri D.C. Hsp60 regulation of tumor cell apoptosis. J. Biol. Chem. 2008, 283:5188-5194.
13. Grossman D., McNiff J.M., Li F.Z., Altieri D.C. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Investig. Dermatol. 1999, 113:1076-1081.
14. Huang C.L., Liu D., Nakano J., Yokomise H., Ueno M., Kadota K., Wada H. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non-small-cell lung cancer. Clin. Cancer Res. 2007, 13:6938-6946.
15. Imanishi Y., Hosokawa Y., Yoshimoto K., Schipani E., Mallya S., Papanikolaou A., Kifor O., Tokura T., Sablosky M., Ledgard F., Gronowicz G., Wang T.C., Schmidt E.V., Hall C., Brown E.M., Bronson R., Arnold A. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J. Clin. Invest. 2001, 107:1093-1102.
16. Islam A., Kageyama H., Takada N., Kawamato T., Takayasu H., Isogai E., Ohira M., Hashizume K., Kobayashi H., Kaneko Y., Nakagawara A. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000, 19:617-623.
17. Jiang Y.Y., de Bruin A., Caldas H., Fangusaro J., Hayes J., Conway E.M., Robinson M.L., Altura R.A. Essential role for survivin in early brain development. J. Neurosci. 2005, 25:6962-6970.
18. Johnson E.A., Svetlov S.I., Wang K.K.W., Hayes R.L., Pineda J.A. Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats. Exp. Brain Res. 2005, 167:17-26.
19. Kanwar J.R. Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease. Curr. Med. Chem. 2005, 12:2947-2962.
20. Kanwar J.R., Harrison J.E.B., Wang D.M., Leung E., Mueller W., Wagner N., Krissansen G.W. Beta 7 integrins contribute to demyelinating disease of the central nervous system. J. Neuroimmunol. 2000, 103:146-152.
21. Kanwar J.R., Shen W.P., Kanwar R.K., Berg R.W., Krissansen G.W. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J. Natl Cancer Inst. 2001, 93:1541-1552.
22. Kanwar J.R., Kanwar R.K., Krissansen G.W. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 2004, 127:1313-1331.
23. Kanwar J.R., Shen W.P., Kanwar R.K., Sun X.Y., Berg R.W., Krissansen G.W. Survivin antagonists and antisense HIF-1α stimulates the generation of tumor-specific CTLs: may be beneficial for the treatment of large lymphomas. Cancer Gene Ther. 2004, 11:853.
24. Kanwar J.R., Kanwar R.K., Burrow H., Baratchi S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr. Med. Chem. 2009, 16:2373-2394.
25. Kanwar R.K., Cheung C.H.A., Chang J.Y., Kanwar J.R. Recent advances in antisurvivin treatments for cancer. Curr. Med. Chem. 2010, 17:1509-1515.
26. Kells A.P., Connor B. AAV-mediated expression of Bcl-X-L or XIAP fails to induce neuronal resistance against quinolinic acid-induced striatal lesioning. Neurosci. Lett. 2008, 436:326-330.
27. Khan S., Aspe J.R., Asumen M.G., Almaguel F., Odumosu O., Acevedo-Martinez S., De Leon M., Langridge W.H.R., Wall N.R. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br. J. Cancer 2009, 100:1073-1086.
28. Lens S.M.A., Rodriguez J.A., Vader G., Span S.W., Giaccone G., Medema R.H. Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Mol. Biol. Cell 2006, 17:1897-1909.
29. Li F.Z., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584.
30. Li L., Feng T.T., Lian Y.Y., Zhang G.F., Garen A., Song X. Role of human noncoding RNAs in the control of tumorigenesis. PNAS-USA 2009, 106:12956-12961.
31. Lindvall O., Kokaia Z., Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Rev. Neurosci. 2004, S42-S50.
32. Liste I., Garcia-Garcia E., Bueno C., Martinez-Serrano A. Bcl-X-L modulates the differentiation of immortalized human neural stem cells. Cell Death Differ. 2007, 14:1880-1892.
33. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-delta delta c) method. Methods 2001, 25:402-408.
34. Lovat P.E., Irving H., AnnicchiaricoPetruzzelli M., Bernassola F., Malcolm A.J., Pearson A.D.J., Melino G., Redfern C.P.F. Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout. J. Natl Cancer Inst. 1997, 89:446-452.
35. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 2007, 8:755-765.
36. Makrantoni V., Stark M.J.R. Efficient chromosome Biorientation and the Tension Checkpoint in Saccharomyces cerevisiae both require BIR1. Mol. Cell. Biol. 2009, 29:4552-4562.
37. Maris J.M., Matthay K.K. Molecular biology of neuroblastoma. J. Clin. Oncol. 1999, 17:2264-2279.
38. Marusawa H., Matsuzawa S., Welsh K., Zou H., Armstrong R., Tamm I., Reed J.C. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 2003, 22:2729-2740.
39. Nieto M., Schuurmans C., Britz O., Guillemot F. Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors. Neuron 2001, 29:401-413.
40. Ostenfeld T., Svendsen C.N. Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells. Stem Cells 2004, 22:798-811.
41. Ozisik K., Ozisik P., Yildirim E., Misirlioglu M., Tuncer S. Expression of antiapoptotic survivin and aven genes in rat heart tissue after traumatic brain injury. Transplant. Proc. 2006, 38:2784-2787.
42. Ruchaud S., Carmena M., Earnshaw W.C. The chromosomal passenger complex: one for all and all for one. Cell 2007, 131:230-231.
43. Shankar S.L., Mani S., O'Guin K.N., Kandimalla E.R., Agrawal S., Shafit-Zagardo B. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J. Neurochem. 2001, 79:426-436.
44. Shen C.X., Liu W.J., Buck A.K., Reske S.N. Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells. Anticancer Res. 2009, 29:1423-1428.
45. Shi Z., Liang Y.J., Chen Z.S., Wang X.H., Ding Y., Chen L.M., Fu L.W. Overexpression of survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Oncol. Rep. 2007, 17:969-976.
46. Skoufias D.A., Mollinari C., Lacroix F.B., Margolis R.L. Human survivin is a kinetochore-associated passenger protein. J. Cell Biol. 2000, 151:1575-1581.
47. Sonee M., Martens J.R., Evers M.R., Mukherjee S.K. The effect of tertiary butylhydroperoxide and nicotinamide on human cortical neurons. Neurotoxicology 2003, 24:443-448.
48. Sun Y., Nadal-Vicens M., Misono S., Lin M.Z., Zubiaga A., Hua X.X., Fan G.P., Greenberg M.E. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 2001, 104:365-376.
49. Tumes D.J., Connolly A., Dent L.A. Expression of survivin in lung eosinophils is associated with pathology in a mouse model of allergic asthma. Int. Immunol. 2009, 21:633-644.
50. Wainwright L.J., Lasorella A., Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc. Natl Acad. Sci. USA 2001, 98:9396-9400.
51. Wheatley S.P., Henzing A.J., Dodson H., Khaled W., Earnshaw W.C. Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. J. Biol. Chem. 2004, 279:5655-5660.
52. Xu D.G., Bureau Y., McIntyre D.C., Nicholson D.W., Liston P., Zhu Y.X., Fong W.G., Crocker S.J., Korneluk R.G., Robertson G.S. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci. 1999, 19:5026-5033.
53. Yan H., Thomas J., Liu T., Raj D., London N., Tandeski T., Leachman S.A., Lee R.M., Grossman D. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable survivin antagonist. Oncogene 2006, 25:6968-6974.
54. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 2001, 21:2661-2668.